Shares of Sintx Technologies, Inc. (NASDAQ: SINT) rose sharply in today’s pre-market trading after the company announced its subsidiary Technology Assessment & Transfer entered into a Cooperative Research and Development agreement with the U.S.
The total committed funding is expected to provide sufficient capital to fund Talphera through a potential FDA approval of Niyad™, targeted for the first half of 2025$16 million of total equity committed with $6